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Abstract
Sample size calculations for a group-randomized trial (GRT) require an estimate of the expected 
intraclass correlation coefficient (ICC). However, few ICC estimates from GRTs in HIV/AIDS 
research have been published, leaving investigators with little data on which to base expectations. 
We used data from a multi-country study to estimate ICCs for variables related to physical and 
mental health and HIV risk behaviors. ICCs for perceptions of physical and mental health tended 
to be higher than those for HIV risk behavior variables, which were higher than ICCs for CD4 
count. Covariate adjustment for country and socio-demographic variables reduced most ICC 
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estimates. For risk behavior variables, adjustment for country and socio-demographic variables 
reduced ICC estimates by as much as 84 %. Variability in ICC estimates has important 
implications for study design, as a larger ICC reduces power. ICC estimates presented in this 
analysis will allow more precise sample size estimates for future GRTs.
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Introduction
Cluster or group-randomized trials (GRTs) are often used to test the efficacy of HIV 
prevention interventions [1, 2]. In GRTs, intact social groups (e.g. clinics, communities, or 
schools), rather than individual participants, are randomly assigned to study conditions. This 
study design is used when individual randomization is not feasible either because the 
intervention is targeted at the community or structural level, or when investigators are 
concerned about contamination of study conditions due to frequent interaction between 
participants. GRTs have been used in resource-limited settings to test a number of HIV 
prevention interventions including HIV testing and counseling [3], peer education [4–6], 
mass media [7, 8], risk reduction counseling [9], and treatment of sexually transmitted 
infections [5, 10–12].
Individuals within groups in GRTs tend to share characteristics and experiences, inducing 
correlation among observations within groups and violating the assumption of independence 
of observations required by many statistical tests. Failure to adjust for this within-group 
correlation in analyses can increase the chance that an investigator will incorrectly observe a 
difference between the two study conditions when no difference actually exists (i.e. inflate 
the risk of a type I error) [13, 14].
The amount of similarity among observations in GRTs is typically quantified by the 
intraclass correlation coefficient (ICC). Values of the ICC generally range from 0 to 1 
(though they can be negative) and vary by type of outcome variable, group type, and group 
size [15]. To ensure that a GRT is adequately powered, the sample size must be increased by 
a variance inflation factor (VIF; also called a “design effect”) [13]. The VIF is [1 + (m − 1) 
ICC], where m is the average group size. Both the magnitude of the ICC and group size will 
impact power to detect an effect, though group size has less of an impact than the number of 
groups [13]. To properly calculate the VIF and the sample size needed for a GRT, 
investigators should have an accurate estimate of the expected ICC based on prior studies. 
However, very few HIV trials have published ICC estimates [16] and even fewer have 
published these estimates for resource-limited settings [16]. A 2004 extension of the 
CONSORT statement for cluster-randomized trials requires investigators reporting the 
results of cluster-randomized trials to report both the ICC used for sample size estimation 
and ICCs for primary outcomes [17], but few investigators in HIV prevention seem aware of 
this requirement [18].
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Covariate adjustment in analysis of a GRT can reduce the magnitude of an ICC by 
explaining between-group variation, and a reduced ICC will improve the power of a study to 
detect an intervention effect [15]. However, covariate adjustment can also decrease power 
by increasing between-group variation and making the ICC larger. The increase is due to 
confounding. In the unadjusted data, the members of a group appear less similar than they 
really are due to the uneven distribution of a covariate among the groups. Adjustment for the 
covariate reveals the confounding, as the members of a group now appear more similar to 
one another than to members of other groups, reflected in higher ICC. Therefore, it is 
beneficial to explore not just ICC estimates, but also the impact of covariate adjustment on 
ICC estimates using covariates other investigators are likely to measure.
This paper presents ICC estimates from a GRT evaluating a clinic-based HIV prevention 
intervention conducted in sub-Saharan Africa. We provide ICC estimates for a variety of 
common variables related to HIV risk behavior and physical and mental health, and compare 
unadjusted ICCs with ICCs adjusted for key covariates to determine where covariate 
adjustment can reduce ICCs. We then demonstrate sample size estimation for GRTs using 
our ICC estimates. The ICC estimates from this analysis will allow investigators planning 




The HIV Prevention for People Living with HIV Project was a group randomized controlled 
trial evaluating a clinic-based HIV prevention intervention for people living with HIV. 
Eighteen HIV care and treatment clinics in three sub-Saharan African countries (Kenya, 
Namibia and Tanzania) were paired on clinic characteristics (e.g. number of patients 
enrolled in care, health care provider/patient ratio) and then randomly assigned to either the 
intervention or control arm. A detailed report of the study design, intervention and patient 
characteristics was previously published [19]. Approximately 200 patient participants were 
enrolled from each clinic and interviewed using a structured questionnaire at baseline and 6- 
and 12-months post-intervention. For this analysis, we used data collected at baseline from 
patient questionnaires and medical chart reviews.
Study Measures
Physical Health—ICCs were estimated for several measures of study participants’ 
physical health status. CD4 count (cells/mm3) is presented as a continuous variable and as 
two categorical variables representing different thresholds for anti-retroviral treatment 
initiation. Participants’ level of HIV medication adherence within the past 30 days was 
measured in two ways. They were first asked to report how many times they had missed a 
dose of their prescribed medication(s). Participants were then shown a visual analog scale 
(VAS) and asked to mark their level of HIV medication adherence on the scale. Physical 
functioning and mental health over the past 30 days was assessed using the SF-8 Health 
Survey, an 8-item scale [20, 21].
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Mental Health—The Center for Epidemiologic Studies Depression Scale (CES-D Scale) 
was used to assess symptoms of depression experienced by participants over the previous 
week [22]. Social support (physical, emotional, and other support) was assessed with an 8-
item measure. The last question asked whether someone would be able to take care of the 
participants’ children if he/she was sick. The total score for participants without children 
was multiplied by 8/7 to preserve the range of 0–8 for all respondents.
HIV Risk Behaviors
Disclosure and Knowledge of Partners Status: Participants were asked whether they had 
disclosed their HIV status to sex partners and/or disclosed to anyone else. Participants were 
also asked whether their sex partners had been tested for HIV and whether they knew the 
HIV status of each partner.
Condom/Contraceptive Use: Participants reported how many times they had sex and how 
many times they used condoms during vaginal sex in the past 90 days and in the past 14 
days, and a dichotomous “consistent condom use” variable was created from these question. 
Participants also reported whether they used a condom during their last act of vaginal sex. 
Dual contraceptive method use was defined as consistent condom use in addition to one of 
the following methods of contraception: oral contraceptive pills, intra-uterine device (IUD), 
injectables, implants or female sterilization.
Other HIV Risk Behaviors: Questions about exchanging sex for a place to stay, money, 
food and/or gifts during the past 6 months were collapsed into one dichotomous sex 
exchange variable (yes/no). Female participants were asked whether someone had hit, 
slapped, kicked or inflicted physical harm upon them and/or forced them to have sexual 
intercourse or perform sexual acts within the past 6 months (intimate partner violence) The 
World Health Organization’s Alcohol Use Disorders Identification Test (AUDIT), a 10-item 
scale, was used to assess participants’ alcohol use [23]. ICCs from this scale are presented in 
two ways: (1) as a dichotomous variable comparing non-drinker/non-harmful drinker versus 
harmful/likely dependent drinker the over a 6-month period; and (2) as a dichotomous 
variable (yes/no) indicating any binge drinking during the past 6 months. A cutoff of 8 on 
the AUDIT scale was used to categorize participants into the harmful/likely dependent 
drinker category. Binge drinking was defined as consuming 6 or more drinks on one 
occasion.
Statistical Methods
We calculated ICCs for each of the outcome measures of interest including binary and 
continuous variables by using the following equation:
where  is the between group component of variance and  is the within group component 
of variance, following the notation of Murray [24]. For the present analyses, g represents the 
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clinic, and m represents participants within clinic. We estimated ICCs: (1) without 
covariates, (2) with country as a covariate, and (3) with country and other socio-
demographics including, gender, age, any paid work and time since HIV diagnosis as 
covariates. Among the three models, the two adjusted models were compared with the 
unadjusted model by using the percentage change in the ICC estimate using the formula: 
ICCchange = (ρadj − ρunadj)/ρunadj × 100.
We used SAS version 9.2 [25] to conduct all analyses. We estimated the variance 
component for clinic and participants within each clinic by using the SAS GLIMMIX 
procedure to fit generalized linear mixed models for binary variables and PROC MIXED to 
fit linear mixed models for continuous variables. For binary variables, the variance 
components were converted from logit scale to the linear scale before calculating the ICC 
[24]. Lower and upper confidence limits were calculated as [26]:
where F = [ICC*(m − 1) + 1]/(1 − ICC), m is the average number of members per group, FL 
is the value from the F-distribution at α = 0.025, with m − 1 numerator and g*(m − 1) 
denominator degrees of freedom, and FU is the value from the F-distribution at α = 0.975 
with the same degrees of freedom.
Results
A total of 3,538 study participants, of whom 2,054 (58 %) were female, completed baseline 
patient questionnaires in the 18 clinics. A full socio-demographic profile of study 
participants has been previously presented [19]. Table 1 presents descriptive statistics, ICC 
estimates and 95 % confidence intervals for the physical and mental health variables. The 
unadjusted ICC estimates ranged from 0.012 for CD4 counts less than 350 cells/mm3 to 
0.019 for CD4 counts less than 200 cells/mm3. When we just adjusted for country, the ICC 
estimates for these two variables increased slightly. However, after adjusting for all 
covariates including country, gender, age, any paid work and time since HIV diagnosis, 
ICCs for the three CD4 count variables decreased as much as 33 %. ICC estimates for 
medication adherence during the past 30 days were 0.029 for any missed doses and 0.041 for 
the visual analog scale. After adjusting for covariates, these values increased slightly.
The ICC estimates for physical and mental functioning were 0.043 and 0.060, respectively. 
Those for social support and depression were 0.076 and 0.090, respectively. The percent 
reduction in covariate-adjusted ICCs ranged from about 8 % to over 16 %.
Table 2 presents descriptive statistics and ICC estimates for HIV risk behavior variables. 
ICC estimates were 0.027 for disclosure to anyone and 0.039 for disclosure to sex partners 
and these were reduced by about 20 and 60 % respectively with covariate adjustment. After 
covariate adjustment, the ICC estimate for knowing whether the partner was tested for HIV 
decreased while the estimate for knowing the partner’s HIV status increased slightly. ICC 
estimates for the three condom use variables were 0.020 for condom use during the past 14 
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days, 0.038 for condom use during the past 90 days, and 0.055 for condom use at the last 
sexual encounter. Covariate adjustment reduced the estimates for the three condom use 
variables substantially, with percent change ranging from about −40 % to over −80 %. The 
ICC estimate for dual method use was 0.049 and decreased about 35 % after covariate 
adjustment.
Covariate adjustment decreased the estimate for any sex exchange during the past 6 months 
by about 20 %. The ICC estimate for IPV was 0.008 and this estimate decreased by 25 % 
following covariate adjustment. The ICC estimate for both binge drinking and harmful/
likely dependent drinking was 0.030. After covariate adjustment, the ICC estimates for both 
variables decreased substantially.
Discussion
This paper is unique in its presentation of ICC estimates for behavioral and clinical variables 
from an HIV prevention intervention in a resource-limited setting. Though estimates varied 
widely, we can point to some general trends likely to be helpful to investigators. ICCs for 
patients’ perceptions of their physical functioning and mental health tended to be higher than 
those for HIV risk behavior variables. ICCs for CD4 count were lower than most of the HIV 
risk behavior variables. The lowest ICCs were observed among three behavior variables 
including knowledge of a sex partner’s HIV status, any sex exchange during the past 6 
months, and (for female participants only) any experience with intimate partner violence 
during the past 6 months. Our ICCs follow the pattern noted by others that unadjusted ICCs 
tend to be smallest for physiological measures, higher for behaviors, and highest for 
knowledge, attitude, and belief measures [15, 27].
Overall, covariate adjustment reduced ICC estimates for most variables. For HIV risk 
behavior variables, adjustment for the country reduced ICCs by as much as 79 %. Adding 
socio-demographic covariates, after adjusting for country, further decreased ICCs for most 
variables except for knowledge of a sex partner’s HIV status and sex exchange during the 
past 6 months. The often substantial decreases observed in the magnitude of the ICC 
estimate after covariate adjustment can significantly impact the number of groups required 
to adequately power a GRT, lowering costs and participant burden. It is most beneficial to 
have multiple estimates of ICCs of interest and demonstrations of the impact of adjustment 
for covariates because ICCs and the effect of covariate adjustment vary due to sampling 
error and differences in study characteristics.
Only one other publication that we are aware of reports ICCs for sexual risk behavior 
variables [27]. These ICCs were estimated using data from a recent intervention trial testing 
the effectiveness of a condom awareness campaign. Although the target population and 
setting differ (young women in western US cities), the ICC estimates are surprisingly similar 
to ours. For example, the adjusted ICC estimate for any unprotected sex during the past 90 
days (among those who ever had sex) was 0.0143 at the baseline assessment, and our ICC 
estimate for the same variable was 0.006. ICC estimates for condom use at last sex were also 
very similar at 0.0163 for the 2009 study and 0.013 for the current study.
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When estimating sample size for a GRT, it is desirable to identify published ICC estimates 
for the same variable using data from a similar study design and target population as those in 
the study being planned. However, if this is not possible due to the scarcity of published 
estimates, investigators are encouraged to explore available datasets from past similar 
studies to estimate ICCs. For this purpose, cross-sectional data may be used if the dataset 
contains a variable indicating group (cluster) membership. If no such data are available, 
investigators should use published estimates for as similar a study as possible to the one 
being planned, keeping in mind that ICC are generally larger for (1) smaller clusters (e.g. 
clinics vs. entire communities), (2) behavioral or attitudinal variables (vs. physiologic 
variables), and (3) studies that do not include multiple timepoints, as including time in the 
analysis has been demonstrated to reduce ICCs appreciably [15]. ICC estimates used for 
sample size estimation can be modified following those general guidelines, and a sensitivity 
analysis (varying the ICC to determine the impact on needed sample size) should be done to 
ensure that if the ICC is larger than expected, the study will still have sufficient power to 
detect the expected intervention effect.
To illustrate how ICC estimates can be used to calculate the sample size requirements for a 
simple cross-sectional comparison between two study conditions in a group randomized 
trial, consider the following formula, adapted from Murray [24]:
Where g is the number of groups per condition,  and  are the event rate in the two study 
conditions; m is the average number of members per group (clinic); ICCm:g:c is the 
intraclass correlation coefficient measuring the correlation of members nested within groups, 
nested within study condition; and tcritical:α/2 and tcritical:β are critical values from the t-
distribution. About 76 % of participants reported consistent condom use in the past 90 days 
and the ICC estimate for this variable was 0.039 (Table 2). If we assume 200 participants in 
each group, in order to have 80 % power at the 0.05 significance level to detect a minimum 
10 % increase in the proportion of condom use in the intervention group, we would need 
about 12 groups per condition. If the ICC drops to about 0.004, as was the case with our 
covariate adjustment, only about 4 groups per condition would be required. This 
demonstrates how variation in ICC estimates can dramatically change the sample size 
necessary to maintain adequate power to detect an intervention effect.
This analysis has several limitations. First, the relatively small number of groups resulted in 
wider confidence intervals than would be the case if we had more groups. Second, the ICC 
estimates for these variables were derived from an HIV/AIDS prevention trial conducted 
among HIV-positive patients attending HIV clinical care in a resource-limited setting. It 
may be difficult to generalize these ICC estimates to other populations and settings. This 
highlights the need for investigators working in other settings and with other populations to 
publish their ICC estimates.
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Reviews have shown that very few publications of GRTs include evidence of power 
calculations that have adequately considered the ICC effect. Given the high cost and 
participant burden associated with GRTs, it is imperative that these studies are adequately 
powered to detect an intervention effect. ICCs used to estimate sample size for a study 
should always be reported in the paper reporting the trial results, as required by the 
CONSORT extension for cluster-randomized trials [17]. This practice will allow others to 
evaluate the assumptions sample size estimates were based on, and to use the ICC estimates 
for planning future trials. Investigators should also consider reporting ICCs for other 
variables they measured that might be used as outcome variables in future trials, and 
exploring the impact of covariate adjustment on ICC estimates. We hope that the unadjusted 
and covariate-adjusted ICCs we provided will allow investigators planning similar trials to 
more precisely estimate the required sample size.
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